Arven Pharmaceuticals
Pharmaceutical Manufacturing • 
Besiktas, Istanbul, Türkiye • 101-200 Employees
Company overview
| Headquarters | AKMERKEZ B3 KULE KAT 11, Beşiktaş, İSTANBUL 34337, TR |
| Phone number | +902123392000 |
| Website | |
| NAICS | 3254 |
| SIC | 873 |
| Keywords | Biotechnology, Biotechnology Product Development, Inhalation, Inhalation Product Development, G-Csf, Filgrastim |
| Founded | 2013 |
| Employees | 101-200 |
| Socials |
Key Contacts at Arven Pharmaceuticals
Zafer Toksoz
President And Founder
Suna Ayitkan
Art Director
Salih Oğuz Yeşiltepe
Medical Director
Arven Pharmaceuticals Email Formats
Arven Pharmaceuticals uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@arvenilac.com.tr), used 87.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@arvenilac.com.tr | 87.5% |
{first initial}{last name} | jdoe@arvenilac.com.tr | 12.5% |
About Arven Pharmaceuticals
Arven started to develop inhalation products and biologics in 2007. Main goal of the company is to focus on specific product areas and -difficult to make- products. Taking into account the rapidly changing dynamics of global regulatory environment, Toksoz Group decided to start up Arven dedicated only to development and manufacture of inhalation products and biologics. To support this vision, Arven established teams of highly qualified and dedicated research scientists, as well as build a brand new 28,000 square meter manufacturing facility located in the Kirklareli, Turkey. Arven strives for developing products for global market, with strategy of “One Product Globally”. Arven is the first Turkish company developing a biosimilar for global markets, including USA and EU Development of biosimilars are carried out according to international guidelines and regulations including WHO, ICH, FDA and EMA Arven’s expertise includes: • Production of therapeutic proteins • Determination of Quality of therapeutic proteins • Head to head comparison with reference products • Analytical similarity studies • Bioassay studies • Receptor binding studies and others ARVEN is growing with the motto "We design technology for the future and we provide future for human health"
Arven Pharmaceuticals revenue & valuation
| Annual revenue | $62,500,000 |
| Revenue per employee | $493,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $200,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Arven Pharmaceuticals has 22 employees across 8 departments.
Departments
Number of employees
Funding Data
Arven Pharmaceuticals has never raised funding before.
Arven Pharmaceuticals Tech Stack
Discover the technologies and tools that power Arven Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Operating systems
JavaScript libraries
JavaScript libraries
Webmail
Programming languages
Blogs
UI frameworks
Web frameworks
Translation
SSL/TLS certificate authorities
Singapore
Estonia
South Africa
Netherlands
United States
United Kingdom
Taiwan, Province of China
BelgiumFrequently asked questions
4.8
40,000 users
